In the stromal cells, absence or loss of stromal CAV1 immunostaining is a novel indicator of poor prognosis in various human cancers, such as breast [13, 14], gastric[15] and prostate carcinomas[16], as well as in metastatic melanoma [17]. This evidence concerns the gene CAV1 and cancer.